Balance Sheet Thermo Fisher Scientific, Inc.

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 18/05/2026 BST			5-day change	1st Jan Change
442.00 ^USD	+0.83%		-2.34%	-23.72%

05-15	Thermo Fisher Likely to Benefit From End-Market Recovery, but Structural Risks Remain, RBC Says	MT
05-13	Nuvation Bio Collaborates With Thermo Fisher Scientific For Lung Cancer Treatment	DJ

b18747482a0937b8c97f8bf5ff660d.HfLu7slLo3M-vWbqMNjeuUjQYyqmiuQXheQTvl18jps.c6eUjK5yxwV3xR67R7yE8yGkOVDt4adGxLBq_BcNx91EmJaHoiPzH3yIKw

Published financial data: THERMO FISHER SCIENTIFIC, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	39.21B	44.92B	42.86B	42.88B	44.56B
Other Revenues, Total	-	-	-	-	-1M
Total Revenues	39.21B	44.92B	42.86B	42.88B	44.56B
Cost of Goods Sold, Total	19.57B	25.92B	25.74B	25.13B	26.25B
Gross Profit	19.64B	19B	17.11B	17.75B	18.3B
Selling General & Admin Expenses, Total	8B	8.94B	8.38B	8.6B	8.53B
R&D Expenses	1.41B	1.47B	1.34B	1.39B	1.4B
Other Operating Expenses	3M	-	1M	30M	20M
Other Operating Expenses, Total	9.41B	10.41B	9.72B	10.02B	9.94B
Operating Income	10.23B	8.59B	7.39B	7.73B	8.36B
Interest Expense, Total	-536M	-726M	-1.38B	-1.39B	-1.42B
Interest And Investment Income	43M	272M	879M	1.08B	993M
Net Interest Expenses	-493M	-454M	-496M	-312M	-426M
Income (Loss) On Equity Invest.	-4M	-172M	-59M	-42M	-41M
Currency Exchange Gains (Loss)	162M	102M	-29M	-16M	66M
Other Non Operating Income (Expenses)	-161M	-35M	5M	5M	-89M
EBT, Excl. Unusual Items	9.73B	8.03B	6.82B	7.37B	7.87B
Restructuring Charges	-37M	-95M	-233M	-104M	-197M
Merger & Related Restructuring Charges	-35M	-	-	-	-4M
Gain (Loss) On Sale Of Investments	66M	-161M	-46M	21M	-38M
Gain (Loss) On Sale Of Assets	-	14M	-	-	-
Asset Writedown	-122M	-60M	-219M	-252M	-94M
Legal Settlements	-	-	-19M	-	-
Other Unusual Items	-767M	-63M	-59M	-39M	-267M
EBT, Incl. Unusual Items	8.84B	7.66B	6.24B	7B	7.27B
Income Tax Expense	1.11B	703M	284M	657M	547M
Earnings From Continuing Operations	7.73B	6.96B	5.96B	6.34B	6.72B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	7.73B	6.96B	5.96B	6.34B	6.72B
Minority Interest	-3M	-10M	40M	-3M	-17M
Net Income - (IS)	7.72B	6.95B	6B	6.34B	6.7B
Net Income to Common Incl Extra Items	7.72B	6.95B	6B	6.34B	6.7B
Net Income to Common Excl. Extra Items	7.72B	6.95B	6B	6.34B	6.7B
Per Share Items
Net EPS - Basic	19.61	17.73	15.53	16.58	17.78
Basic EPS - Continuing Operations	19.61	17.73	15.53	16.58	17.78
Basic Weighted Average Shares Outstanding	394M	392M	386M	382M	377M
Net EPS - Diluted	19.46	17.63	15.45	16.53	17.74
Diluted EPS - Continuing Operations	19.46	17.63	15.45	16.53	17.74
Diluted Weighted Average Shares Outstanding	397M	394M	388M	383M	378M
Normalized Basic EPS	15.43	12.77	11.14	12.05	13
Normalized Diluted EPS	15.31	12.71	11.08	12.02	12.96
Dividend Per Share	1.04	1.2	1.4	1.56	1.72
Payout Ratio	5.11	6.55	8.72	9.2	9.49
American Depositary Receipts Ratio (ADR)	0.02	0.02	0.02	0.02	0.02
Supplemental Items
EBITDA	12.82B	11.97B	10.8B	10.84B	11.14B
EBITA	11.99B	10.98B	9.73B	9.69B	10.09B
EBIT	10.23B	8.59B	7.39B	7.73B	8.36B
EBITDAR	13.14B	12.43B	11.27B	11.31B	11.64B
Total Revenues (As Reported)	39.21B	44.92B	42.86B	42.88B	44.56B
Effective Tax Rate - (Ratio)	12.55	9.17	4.55	9.39	7.53
Current Domestic Taxes	606M	1.07B	378M	691M	528M
Current Foreign Taxes	1.15B	633M	1.21B	1.18B	658M
Total Current Taxes	1.75B	1.7B	1.58B	1.87B	1.19B
Deferred Domestic Taxes	-246M	-683M	-653M	-1.14B	-419M
Deferred Foreign Taxes	-399M	-314M	-647M	-72M	-221M
Total Deferred Taxes	-645M	-997M	-1.3B	-1.21B	-640M
Normalized Net Income	6.08B	5.01B	4.3B	4.6B	4.9B
Non-Cash Pension Expense	-6M	-16M	-5M	0	3M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.41B	1.47B	1.34B	1.39B	1.4B
Net Rental Expense, Total	320M	460M	470M	468M	497M
Imputed Operating Lease Interest Expense	46.57M	73.7M	142M	150M	153M
Imputed Operating Lease Depreciation	273M	386M	328M	318M	344M
Stock-Based Comp., Other (Total)	230M	307M	278M	301M	310M
Total Stock-Based Compensation	230M	307M	278M	301M	310M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	4.48B	8.52B	8.08B	4.01B	9.85B
Short Term Investments	-	-	-	1.56B	253M
Total Cash And Short Term Investments	4.48B	8.52B	8.08B	5.57B	10.1B
Accounts Receivable, Total	8.94B	9.43B	9.66B	9.63B	10.57B
Other Receivables	-	-	-	-	-
Total Receivables	8.94B	9.43B	9.66B	9.63B	10.57B
Inventory	5.05B	5.63B	5.09B	4.98B	5.42B
Restricted Cash	13M	12M	6M	10M	5M
Other Current Assets, Total	1.63B	1.63B	1.75B	1.95B	2.61B
Total Current Assets	20.11B	25.23B	24.59B	22.14B	28.71B
Gross Property Plant And Equipment	14.12B	15.86B	17.08B	17.55B	19.83B
Accumulated Depreciation	-4.26B	-4.99B	-6.08B	-6.75B	-7.82B
Net Property Plant And Equipment	9.86B	10.87B	11B	10.8B	12.01B
Long-term Investments	63M	154M	45M	438M	438M
Goodwill	41.92B	41.2B	44.02B	45.85B	49.36B
Other Intangibles, Total	20.11B	17.48B	16.71B	15.53B	15.84B
Accounts Receivable Long-Term	9M	7M	4M	6M	1M
Other Long-Term Assets, Total	3.04B	2.22B	2.36B	2.56B	3.98B
Total Assets	95.12B	97.15B	98.73B	97.32B	110B
Liabilities
Accounts Payable, Total	2.87B	3.38B	2.87B	3.08B	3.62B
Accrued Expenses, Total	5.09B	5.12B	4.52B	4.88B	4.98B
Short-term Borrowings	2.52B	310M	-	-	-
Current Portion of Long-Term Debt	-	5.26B	3.6B	2.2B	3.52B
Current Portion of Leases	281M	283M	268M	273M	284M
Current Income Taxes Payable	-	-	-	-	-
Unearned Revenue Current, Total	2.66B	2.6B	2.69B	2.85B	2.71B
Other Current Liabilities	18M	57M	63M	50M	72M
Total Current Liabilities	13.44B	17.01B	14.01B	13.33B	15.19B
Long-Term Debt	32.15B	28.8B	31.41B	28.93B	35.65B
Long-Term Leases	1.39B	1.51B	1.43B	1.43B	1.4B
Unearned Revenue Non Current	1.24B	1.18B	1.5B	1.14B	1.18B
Pension & Other Post Retirement Benefits	504M	323M	383M	355M	382M
Deferred Tax Liability Non Current	3.84B	2.85B	1.92B	1.27B	1.49B
Other Non Current Liabilities	1.6B	1.34B	1.23B	1.2B	1.51B
Total Liabilities	54.15B	53.01B	51.88B	47.65B	56.81B
Common Stock, Total	439M	441M	442M	444M	445M
Additional Paid In Capital	16.17B	16.74B	17.29B	17.96B	18.56B
Retained Earnings	35.43B	41.91B	47.36B	53.1B	59.16B
Treasury Stock	-8.92B	-12.02B	-15.13B	-19.23B	-22.31B
Comprehensive Income and Other	-2.33B	-3.1B	-3.22B	-2.7B	-2.45B
Total Common Equity	40.79B	43.98B	46.74B	49.58B	53.41B
Minority Interest	184M	170M	107M	87M	129M
Total Equity	40.98B	44.15B	46.84B	49.67B	53.54B
Total Liabilities And Equity	95.12B	97.15B	98.73B	97.32B	110B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	391M	385M	381M	377M	371M
ECS Total Common Shares Outstanding	394M	391M	387M	381M	376M
Book Value / Share	103.42	112.62	120.87	130.22	141.96
Tangible Book Value	-21.24B	-14.7B	-13.99B	-11.8B	-11.79B
Tangible Book Value Per Share	-53.86	-37.63	-36.19	-30.99	-31.35
Total Debt	36.34B	36.16B	36.71B	32.83B	40.86B
Net Debt	31.86B	27.63B	28.63B	27.26B	30.75B
Debt Equivalent of Unfunded Proj. Benefit Obligation	284M	259M	335M	310M	327M
Debt Equivalent Oper. Leases	2.56B	3.68B	3.76B	3.74B	3.98B
Minority Interest, Total (Incl. Fin. Div)	184M	170M	107M	87M	129M
Equity Method Investments, Total	-	-	-	357M	178M
Account Code - Inventory Valuation	5	5	5	5	5
LIFO Reserve, Total	-	-	-	-	-
Inventories - Raw Materials, Total	1.92B	2.4B	2.06B	1.8B	1.88B
Inventories - Work In Process, Total	676M	660M	705M	755M	889M
Inventories - Finished Goods, Total	2.45B	2.57B	2.33B	2.42B	2.66B
Land - (BS)	431M	454M	458M	439M	500M
Buildings, Total	2.58B	3.15B	3.59B	3.73B	4.57B
Machinery, Total	9.59B	7.97B	9.24B	9.86B	11B
Full Time Employees	130K	130K	122K	125K	125K
Accumulated Allowance for Doubtful Accounts (Supple)	150M	189M	193M	173M	147M
Order Backlog	-	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	7.72B	6.95B	6B	6.34B	6.7B
Depreciation & Amortization - CF	831M	986M	1.07B	1.16B	1.05B
Amortization of Goodwill and Intangible Assets - (CF)	1.76B	2.4B	2.34B	1.95B	1.73B
Depreciation & Amortization, Total	2.59B	3.38B	3.41B	3.11B	2.78B
(Gain) Loss From Sale Of Asset	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	230M	307M	278M	301M	310M
Tax Benefit from Stock Options	-	-	-	-	-
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	313M	-435M	-736M	-698M	-168M
Change In Accounts Receivable	-204M	-430M	209M	-333M	-801M
Change In Inventories	-1.06B	-825M	598M	-27M	-74M
Change In Accounts Payable	479M	648M	-500M	212M	421M
Change in Other Net Operating Assets	-758M	-442M	-844M	-231M	-1.35B
Cash from Operations	9.31B	9.15B	8.41B	8.67B	7.82B
Capital Expenditure	-2.52B	-2.24B	-1.48B	-1.4B	-1.52B
Sale of Property, Plant, and Equipment	20M	24M	87M	57M	44M
Cash Acquisitions	-19.4B	-39M	-3.66B	-3.13B	-4.04B
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-1.63B	1.18B
Other Investing Activities, Total	-34M	99M	-90M	260M	289M
Cash from Investing	-21.93B	-2.16B	-5.14B	-5.84B	-4.05B
Short Term Debt Issued, Total	2.51B	1.53B	1.62B	-	1.1B
Long-Term Debt Issued, Total	18.14B	3.19B	5.94B	1.2B	7.76B
Total Debt Issued	20.65B	4.72B	7.56B	1.2B	8.85B
Short Term Debt Repaid, Total	-	-3.69B	-1.94B	-	-1.1B
Long-Term Debt Repaid, Total	-11.74B	-375M	-5.78B	-3.61B	-2.41B
Total Debt Repaid	-11.74B	-4.06B	-7.72B	-3.61B	-3.51B
Issuance of Common Stock	156M	-	-	-	-
Repurchase of Common Stock	-2B	-3B	-3B	-4B	-3B
Common Dividends Paid	-395M	-455M	-523M	-583M	-636M
Common & Preferred Stock Dividends Paid	-395M	-455M	-523M	-583M	-636M
Other Financing Activities, Total	-91M	-9M	56M	194M	90M
Cash from Financing	6.58B	-2.81B	-3.62B	-6.79B	1.8B
Foreign Exchange Rate Adjustments	194M	-139M	-82M	-91M	267M
Net Change in Cash	-5.84B	4.05B	-440M	-4.06B	5.84B
Supplemental Items
Cash Interest Paid	555M	667M	1.38B	1.57B	1.61B
Cash Income Tax Paid (Refund)	2.18B	1.23B	1.48B	1.83B	1.78B
Levered Free Cash Flow	5.49B	5.82B	5.14B	6.63B	4.39B
Unlevered Free Cash Flow	5.83B	6.27B	6B	7.5B	5.28B
Change In Net Working Capital	863M	543M	826M	-659M	1.51B
Net Debt Issued / Repaid	8.91B	654M	-155M	-2.4B	5.35B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.79	5.58	4.72	4.93	5.03
Return on Total Capital	9.51	6.81	5.64	5.82	5.91
Return On Equity %	20.47	16.35	13.09	13.13	13.02
Return on Common Equity	20.52	16.4	13.22	13.15	13.02
Margin Analysis
Gross Profit Margin %	50.08	42.3	39.93	41.39	41.08
SG&A Margin	20.4	19.9	19.56	20.04	19.14
EBITDA Margin %	32.69	26.65	25.2	25.29	25
EBITA Margin %	30.58	24.45	22.71	22.59	22.64
EBIT Margin %	26.08	19.12	17.25	18.04	18.76
Income From Continuing Operations Margin %	19.71	15.5	13.9	14.78	15.08
Net Income Margin %	19.7	15.47	13.99	14.77	15.05
Net Avail. For Common Margin %	19.7	15.47	13.99	14.77	15.05
Normalized Net Income Margin	15.5	11.15	10.03	10.73	11
Levered Free Cash Flow Margin	14.01	12.95	12	15.47	9.85
Unlevered Free Cash Flow Margin	14.86	13.96	14	17.5	11.85
Asset Turnover
Asset Turnover	0.48	0.47	0.44	0.44	0.43
Fixed Assets Turnover	4.74	4.33	3.92	3.93	3.91
Receivables Turnover (Average Receivables)	5.09	4.89	4.49	4.45	4.41
Inventory Turnover (Average Inventory)	4.31	4.85	4.8	4.99	5.05
Short Term Liquidity
Current Ratio	1.5	1.48	1.75	1.66	1.89
Quick Ratio	1	1.06	1.27	1.14	1.36
Operating Cash Flow to Current Liabilities	0.69	0.54	0.6	0.65	0.51
Days Sales Outstanding (Average Receivables)	71.76	74.65	81.3	82.33	82.7
Days Outstanding Inventory (Average Inventory)	84.66	75.24	76.01	73.3	72.31
Average Days Payable Outstanding	44.68	43.03	45.29	43.53	45.8
Cash Conversion Cycle (Average Days)	111.74	106.86	112.02	112.1	109.22
Long Term Solvency
Total Debt/Equity	88.68	81.9	78.37	66.1	76.31
Total Debt / Total Capital	47	45.03	43.94	39.79	43.28
LT Debt/Equity	81.84	68.65	70.11	61.12	69.2
Long-Term Debt / Total Capital	43.38	37.74	39.3	36.8	39.25
Total Liabilities / Total Assets	56.92	54.56	52.55	48.96	51.48
EBIT / Interest Expense	19.08	11.83	5.38	5.56	5.89
EBITDA / Interest Expense	24.51	17.12	8.2	8.14	8.2
(EBITDA - Capex) / Interest Expense	19.81	14.03	7.12	7.13	7.12
Total Debt / EBITDA	2.77	2.91	3.26	2.9	3.51
Net Debt / EBITDA	2.42	2.22	2.54	2.41	2.64
Total Debt / (EBITDA - Capex)	3.42	3.55	3.75	3.31	4.04
Net Debt / (EBITDA - Capex)	3	2.71	2.92	2.75	3.04
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	21.71	14.55	-4.58	0.05	3.91
Gross Profit, 1 Yr. Growth %	22.68	-3.26	-9.79	3.22	3.12
EBITDA, 1 Yr. Growth %	25.74	-7.68	-9.56	-0.37	2.8
EBITA, 1 Yr. Growth %	25.7	-9.49	-11.16	-1.3	4.23
EBIT, 1 Yr. Growth %	29.95	-17.21	-13.62	3.45	8.17
Earnings From Cont. Operations, 1 Yr. Growth %	21.19	-9.94	-14.44	6.43	6.04
Net Income, 1 Yr. Growth %	21.18	-10.03	-13.74	5.67	5.82
Normalized Net Income, 1 Yr. Growth %	31.77	-18.83	-13.85	5.79	6.57
Diluted EPS Before Extra, 1 Yr. Growth %	21.93	-9.4	-12.37	6.99	7.32
Accounts Receivable, 1 Yr. Growth %	38.21	5.39	2.51	-0.39	9.77
Inventory, 1 Yr. Growth %	25.37	11.54	-9.69	-2.16	8.98
Net Property, Plant and Equip., 1 Yr. Growth %	47.51	10.23	1.2	-1.9	11.27
Total Assets, 1 Yr. Growth %	37.76	2.14	1.62	-1.42	13.38
Tangible Book Value, 1 Yr. Growth %	403.53	-30.93	-4.79	-15.43	-0.08
Common Equity, 1 Yr. Growth %	18.22	7.81	6.27	6.1	7.71
Cash From Operations, 1 Yr. Growth %	12.34	-1.7	-8.17	3.1	-9.8
Capital Expenditures, 1 Yr. Growth %	71.17	-11.1	-34.06	-5.34	8.93
Levered Free Cash Flow, 1 Yr. Growth %	-2.26	4.15	-11.34	27.68	-33.76
Unlevered Free Cash Flow, 1 Yr. Growth %	-2.31	5.92	-4.03	23.9	-29.61
Dividend Per Share, 1 Yr. Growth %	18.18	15.38	16.67	11.43	10.26
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	23.9	18.07	4.55	-2.29	1.96
Gross Profit, 2 Yr. CAGR %	31.67	8.95	-6.65	-3.27	3.45
EBITDA, 2 Yr. CAGR %	40.84	8.36	-8.73	-4.71	1.89
EBITA, 2 Yr. CAGR %	42.56	7.33	-10.44	-5.97	2.19
EBIT, 2 Yr. CAGR %	56.31	4.48	-15.57	-4.95	6.84
Earnings From Cont. Operations, 2 Yr. CAGR %	44.56	4.47	-12.22	-4.57	6.24
Net Income, 2 Yr. CAGR %	44.57	4.41	-11.91	-4.53	5.75
Normalized Net Income, 2 Yr. CAGR %	60.08	4.21	-16.52	-3.97	7.33
Diluted EPS Before Extra, 2 Yr. CAGR %	45.68	5.1	-10.9	-3.17	7.16
Accounts Receivable, 2 Yr. CAGR %	34.4	20.69	3.94	1.05	4.56
Inventory, 2 Yr. CAGR %	22.43	18.25	0.37	-6	3.26
Net Property, Plant and Equip., 2 Yr. CAGR %	34.56	27.51	5.62	-0.36	4.48
Total Assets, 2 Yr. CAGR %	27.65	18.62	1.88	0.09	5.72
Tangible Book Value, 2 Yr. CAGR %	45.37	86.64	-18.91	-10.39	-8.07
Common Equity, 2 Yr. CAGR %	17.25	12.89	7.04	6.18	6.9
Cash From Operations, 2 Yr. CAGR %	36.84	5.09	-4.99	-2.7	-3.56
Capital Expenditures, 2 Yr. CAGR %	65.06	23.36	-23.44	-21	1.54
Levered Free Cash Flow, 2 Yr. CAGR %	30.38	1.74	-4.05	6.96	-7.2
Unlevered Free Cash Flow, 2 Yr. CAGR %	26.29	2.53	0.69	9.54	-5.88
Dividend Per Share, 2 Yr. CAGR %	16.98	16.77	16.02	14.02	10.84
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	17.2	20.7	9.98	3.03	-0.27
Gross Profit, 3 Yr. CAGR %	21.8	18.81	2.26	-3.32	-1.19
EBITDA, 3 Yr. CAGR %	27.76	22.8	1.95	-5.78	-2.29
EBITA, 3 Yr. CAGR %	28.72	23.02	0.69	-7.23	-2.71
EBIT, 3 Yr. CAGR %	38.14	27.06	-2.05	-9.32	-0.79
Earnings From Cont. Operations, 3 Yr. CAGR %	38.04	23.47	-2.26	-6.4	-1.16
Net Income, 3 Yr. CAGR %	38.02	23.43	-2.03	-6.4	-1.19
Normalized Net Income, 3 Yr. CAGR %	42.37	28.28	-2.31	-9.3	-0.61
Diluted EPS Before Extra, 3 Yr. CAGR %	39.04	24.34	-1.08	-5.29	0.21
Accounts Receivable, 3 Yr. CAGR %	24.86	23.94	14.3	2.48	3.88
Inventory, 3 Yr. CAGR %	18.9	18.68	8.09	-0.48	-1.25
Net Property, Plant and Equip., 3 Yr. CAGR %	33.29	25.9	18.06	3.05	3.38
Total Assets, 3 Yr. CAGR %	19.15	18.5	12.66	0.76	4.33
Tangible Book Value, 3 Yr. CAGR %	18.59	13.49	49.13	-17.84	-7.07
Common Equity, 3 Yr. CAGR %	13.93	14.01	10.64	6.72	6.69
Cash From Operations, 3 Yr. CAGR %	27.03	22.55	0.47	-2.36	-5.12
Capital Expenditures, 3 Yr. CAGR %	49.31	34.3	0.11	-17.83	-12.07
Levered Free Cash Flow, 3 Yr. CAGR %	19.43	21.63	-2.92	5.91	-8.85
Unlevered Free Cash Flow, 3 Yr. CAGR %	16.97	19.71	0.2	8.22	-5.49
Dividend Per Share, 3 Yr. CAGR %	15.21	16.45	16.74	14.47	12.75
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.5	16.51	11.96	10.92	6.7
Gross Profit, 5 Yr. CAGR %	18.37	14.78	9.5	9.4	2.72
EBITDA, 5 Yr. CAGR %	23	17.9	11.93	10.9	1.79
EBITA, 5 Yr. CAGR %	23.46	17.93	11.6	10.43	1.14
EBIT, 5 Yr. CAGR %	29.53	21.67	13.77	13.06	1.22
Earnings From Cont. Operations, 5 Yr. CAGR %	30.72	25.59	15.18	11.38	1.06
Net Income, 5 Yr. CAGR %	30.74	25.58	15.33	11.38	1.01
Normalized Net Income, 5 Yr. CAGR %	32.33	24.26	15.33	14.17	1.22
Diluted EPS Before Extra, 5 Yr. CAGR %	30.71	25.78	16.37	12.51	2.14
Accounts Receivable, 5 Yr. CAGR %	24.02	19.43	16.03	14.22	10.3
Inventory, 5 Yr. CAGR %	17.94	13.65	11.11	8.11	6.13
Net Property, Plant and Equip., 5 Yr. CAGR %	30.78	21.86	21.45	14.66	12.43
Total Assets, 5 Yr. CAGR %	15.69	11.38	11.92	10.76	9.83
Tangible Book Value, 5 Yr. CAGR %	9.08	-2.36	1.89	3.26	22.82
Common Equity, 5 Yr. CAGR %	13.62	11.59	11.12	10.81	9.13
Cash From Operations, 5 Yr. CAGR %	23.37	17.98	13.1	11.75	-1.16
Capital Expenditures, 5 Yr. CAGR %	41.55	34.58	14.3	8.62	0.68
Levered Free Cash Flow, 5 Yr. CAGR %	17.36	15.92	9.77	15.47	-4.81
Unlevered Free Cash Flow, 5 Yr. CAGR %	16.12	14.77	10.5	15.47	-2.41
Dividend Per Share, 5 Yr. CAGR %	11.63	14.87	15.54	15.47	14.34